A pharmacokinetic study of vaginally and intravenously administered oxytocin in postmenopausal women with vaginal atrophy

Trial Profile

A pharmacokinetic study of vaginally and intravenously administered oxytocin in postmenopausal women with vaginal atrophy

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Oxytocin (Primary) ; Oxytocin (Primary)
  • Indications Atrophic vaginitis
  • Focus Pharmacokinetics
  • Sponsors Peptonic Medical
  • Most Recent Events

    • 30 Aug 2014 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 01 Nov 2013 New source identified and integrated (ClinicalTrials.gov record, NCT01975129).
    • 25 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top